Table 5.
Two-compartment population analysis of IMP288 pharmacokinetics.
| Parametera | k2,1 (h−1) | k1,2 (h−1) | AS | BS | MR | kel (h−1) | Volume/m2 (L/m2) | Vc (L) | Clearance (L/h) |
|---|---|---|---|---|---|---|---|---|---|
| Population values | |||||||||
| Estimation | 0.027 | 0.019 | 1.42 | 0.182 | NA | NA | 6.38 | NA | NA |
| SD | 0.001 | 0.002 | 0.07 | 0.012 | NA | NA | 0.27 | NA | NA |
| Individual values | |||||||||
| Patient 1, indium | 0.027 | 0.021 | 1.35 | 0.169 | 124.2 | 0.226 | 6.69 | 13.4 | 3.04 |
| Patient 1, lutetium | 0.024 | 0.021 | 1.37 | 0.172 | 125.5 | 0.241 | 6.50 | 13.1 | 3.15 |
| Patient 2, indium | 0.026 | 0.023 | 1.31 | 0.167 | 40.7 | 0.250 | 6.54 | 9.7 | 2.43 |
| Patient 2, lutetium | 0.027 | 0.022 | 1.22 | 0.156 | 40.1 | 0.219 | 6.63 | 9.9 | 2.16 |
| Patient 3, indium | 0.028 | 0.015 | 1.53 | 0.199 | 35.7 | 0.185 | 6.23 | 16.8 | 3.11 |
| Patient 3, lutetium | 0.028 | 0.017 | 1.43 | 0.183 | 37.8 | 0.165 | 6.25 | 16.8 | 2.78 |
| Patient 4, indium | 0.026 | 0.026 | 0.92 | 0.141 | 22.6 | 0.112 | 6.90 | 12.7 | 1.43 |
| Patient 4, lutetium | 0.029 | 0.019 | 1.29 | 0.167 | 22.0 | 0.173 | 6.78 | 12.5 | 2.17 |
| Patient 5, indium | 0.027 | 0.017 | 1.53 | 0.196 | 22.5 | 0.235 | 6.15 | 12.0 | 2.82 |
| Patient 5, lutetium | 0.028 | 0.017 | 1.52 | 0.196 | 31.1 | 0.249 | 6.13 | 11.9 | 2.97 |
| Patient 6, indium | 0.027 | 0.019 | 1.41 | 0.179 | 109.0 | 0.291 | 6.44 | 11.2 | 3.25 |
| Patient 6, lutetium | 0.028 | 0.021 | 1.31 | 0.170 | 18.8 | 0.179 | 6.93 | 12.0 | 2.15 |
| Patient 7, indium | 0.027 | 0.022 | 1.41 | 0.181 | 3.3 | 0.146 | 6.21 | 12.0 | 1.76 |
| Patient 7, lutetium | 0.028 | 0.018 | 1.41 | 0.181 | 3.2 | 0.137 | 6.54 | 12.7 | 1.74 |
| Patient 8, indium | 0.028 | 0.018 | 1.44 | 0.182 | 2.3 | 0.161 | 6.18 | 10.4 | 1.68 |
| Patient 8, lutetium | 0.028 | 0.020 | 1.16 | 0.174 | 2.5 | 0.124 | 6.49 | 10.9 | 1.36 |
| Meanb | 0.027 | 0.020 | 1.35 | 0.176 | 0.193 | 6.47 | 12.4 | 2.37 | |
| SD | 0.001 | 0.003 | 0.16 | 0.015 | 0.052 | 0.27 | 2.0 | 0.65 | |
| CV (%) | 4.5 | 14.3 | 11.5 | 8.6 | 27.0 | 4.1 | 16.4 | 27.5 | |
aThe transfer rates (k2,1 and k1,2), the central compartment volume per body surface area unit (m2), and the two parameters A and B were adjusted using a two-compartment model. Estimations of the population adjusted parameters are given together with their estimated SD. The central compartment volume was a dependent parameter (Vc = volume/m2 × patient body surface area). Clearance was calculated as AS × MRBS, MR being the ratio of the number of moles of injected IMP288 to the number of moles of TF2 present in the circulation at the time of IMP288 injection and the elimination constant kel as clearance/Vc.
bThe mean, SD, and CV for each parameters were calculated from individual estimations.